Spain· ES:65744
DISMEGYN CAPSULAS
A medicinal product containing vitex agnus castus, registered in Spain by Kern Pharma S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- Vitex agnus castus
- Manufacturer
- Kern Pharma S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vitex agnus castus in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAgnus castusHahnemann Laboratories, Inc.
- GermanyGynocastusFritz Zilly Gmbh
- FinlandFemonia
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Gynocastus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f02298b-41ce-4bbb-ae8f-b7c77ab29db4 GET /v1/drugs/6f02298b-41ce-4bbb-ae8f-b7c77ab29db4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Sin Receta",
"estado": "{\"aut\":1067209200000}",
"nregistro": "65744",
"substance": "Vitex agnus castus"
}See everything about vitex agnus castus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.